Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).
Saved in:
| Title: | Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV). |
|---|---|
| Authors: | Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis Inserm, Centre d'Investigations Cliniques, INSERM Paris France., Klade C; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Georgiev P; Medical University of Plovdiv Plovdiv Bulgaria., Krochmalczyk D; Teaching Unit of the Hematology Department University Hospital in Krakow Krakow Poland., Gercheva-Kyuchukova L; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic Varna Bulgaria., Egyed M; Department of Internal Medicine II Kaposi Mor County Teaching Hospital Kaposvar Hungary., Dulicek P; Department of Clinical Hematology University Hospital Hradec Kralove Hradec Kralove Czech Republic., Illes A; Faculty of Medicine, Department of Hematology University of Debrecen Debrecen Hungary., Pylypenko H; Department of Hematology Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre Cherkasy Ukraine., Sivcheva L; First Department of Internal Medicine Multiprofile Hospital for Active Treatment - HristoBotev Vratsa Bulgaria., Mayer J; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology Brno Czech Republic., Yablokova V; Department of Hematology Yaroslavl Regional Clinical Hospital Yaroslavl Russia., Krejcy K; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Empson V; AOP Orphan Pharmaceuticals GmbH Vienna Austria., Hasselbalch HC; Department of Hematology Zealand University Hospital, University of Copenhagen Roskilde Denmark., Kralovics R; Department of Laboratory Medicine Medical University of Vienna Vienna Austria., Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation Medical University Vienna Vienna Austria. |
| Corporate Authors: | PROUD‐PV Study Group |
| Source: | HemaSphere [Hemasphere] 2025 May 03; Vol. 9 (5), pp. e70137. Date of Electronic Publication: 2025 May 03 (Print Publication: 2025). |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
